Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand.

AIDS. 1995 Sep;9(9):1093-7. Unique Identifier : AIDSLINE MED/96085727
Cohen CR; Duerr A; Pruithithada N; Rugpao S; Hillier S; Garcia P; Nelson K; Department of Obstetrics and Gynecology, Northwestern University,; Chicago, Illinois, USA.


Abstract: OBJECTIVE: To investigate the relationship between HIV seropositivity and bacterial vaginosis (BV) in a population at high risk for sexual acquisition of HIV. DESIGN: A cross-sectional study was conducted among 144 female commercial sex workers in Chiang Mai, Thailand. METHODS: The participants were tested for cervical gonorrhea and Chlamydia infection, syphilis, Trichomonas vaginitis, Candida vaginitis, BV, and HIV infection. BV was diagnosed by clinical criteria (pH > 4.5, positive amine test, and presence of clue cells) and using Gram stains. RESULTS: Thirty-three per cent of participants had BV, and 43% were HIV-positive. Using clinical criteria, the association of BV and HIV seropositivity was significant [odds ratio (OR), 2.7; 95% confidence interval (CI), 1.3-5.0]. Although the association between BV and HIV prevalence was not significant using Gram stains alone for diagnosis of BV, an association was found between abnormal vaginal flora and HIV (OR, 2.1; 95% CI, 1.0-4.8). In multiple logistic regression analysis, adjusting for age, number of sexual encounters per week, current condom use, and currently having a sexually transmitted disease (STD), both BV and a history of an STD were independently associated with HIV seropositivity (adjusted OR for BV, 4.0 and 95% CI, 1.7-9.4; adjusted OR for history of an STD, 6.9 and 95% CI, 2.1-22.9). CONCLUSIONS: When diagnosed clinically, BV is independently associated with HIV seroprevalence. HIV infection may promote abnormal vaginal flora, or BV may increase susceptibility to sexual transmission of HIV. Alternatively, the association seen here may result from intervening variables; in this case BV may be a marker or a cofactor of HIV transmission.
Keywords: Adolescence Adult Animal AIDS-Related Opportunistic Infections/*EPIDEMIOLOGY/TRANSMISSION Cross-Sectional Studies *Developing Countries Female Human HIV Seroprevalence/*TRENDS Incidence Middle Age Prostitution/*STATISTICS & NUMER DATA Rats Risk Factors Thailand/EPIDEMIOLOGY Urban Population/*STATISTICS & NUMER DATA Vaginosis, Bacterial/*EPIDEMIOLOGY/TRANSMISSION JOURNAL ARTICLEKWDadolescenceadultanimalaids-relatedopportunisticinfections/KWDepidemiology/transmissioncross-sectionalstudiesKWDdevelopingcountriesfemalehumanhivseroprevalence/KWDtrendsincidencemiddleageprostitution/KWDstatistics&numerdataratsriskfactorsthailand/epidemiologyurbanpopulation/KWDstatistics&numerdatavaginosis,bacterial/KWDepidemiology/transmissionjournalarticle
960430
M9640861

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .